Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

827
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
827
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

542
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
542
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

829
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
829
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

2.5K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.5K
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas
  1. Home
  2. Juglone Se Dirige Al Mmp-1 Para Inhibir La Progresión Del Cáncer Gástrico
  1. Home
  2. Juglone Se Dirige Al Mmp-1 Para Inhibir La Progresión Del Cáncer Gástrico

Video Experimental Relacionado

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

2.7K

Juglone se dirige al MMP-1 para inhibir la progresión del cáncer gástrico

Fanghui Zhou1, Yi Xie2, Xuelian Li2

  • 1School of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, China; Department of Gastroenterology, Qiandongnan Miao and Dong Autonomous Prefecture People's Hospital, Kaili, Guizhou, China.

Biochemical pharmacology
|August 30, 2025

Ver abstracta en PubMed

Resumen
Este resumen es generado por máquina.

Juglone, un compuesto natural, inhibe eficazmente el crecimiento, la migración y la invasión del cáncer gástrico al tiempo que mejora la sensibilidad a la quimioterapia. Este estudio destaca Juglone como un producto natural prometedor para el tratamiento del cáncer gástrico con una toxicidad mínima.

Palabras clave:
Sensibilidad a la quimioterapiaCáncer gástricoLa glucólisisMetabolismo de las proteínas de matriz 1La proliferación

Más Videos Relacionados

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.2K

Videos de Experimentos Relacionados

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

2.7K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.2K

Área de la Ciencia:

  • En el campo de la oncología
  • Productos naturales Química
  • La bioinformática

Sus antecedentes:

  • La incidencia de cáncer gástrico está aumentando, con etapas avanzadas que presentan importantes desafíos de tratamiento debido a la resistencia a los medicamentos y los efectos secundarios de la quimioterapia.
  • El desarrollo de nuevas estrategias terapéuticas para el cáncer gástrico es crítico, con productos naturales que muestran una actividad prometedora contra el cáncer.

Objetivo del estudio:

  • Investigar los efectos anticancerígenos y los mecanismos moleculares de Juglone en las células cancerosas gástricas.
  • Evaluar la eficacia y seguridad de Juglone en modelos preclínicos de cáncer gástrico.

Principales métodos:

  • Análisis bioinformático
  • Experimentos celulares in vitro en células de cáncer gástrico
  • Modelos animales in vivo
  • Evaluación de la proliferación, la migración, la invasión, la apoptosis, el ciclo celular y la toxicidad
  • Principales resultados:

    • Juglone inhibió significativamente la proliferación, la migración, la invasión y la transición epitelial-mesenquimal de las células cancerosas gástricas.
    • Juglone indujo la apoptosis y la detención del ciclo celular en las células cancerosas gástricas con una toxicidad mínima para los tejidos normales.
    • Juglone interrumpió la vía glicolítica en las células cancerosas y aumentó la sensibilidad a la quimioterapia con cisplatino.

    Conclusiones:

    • Juglone demuestra una potente actividad contra el cáncer gástrico a través de múltiples mecanismos, incluida la interrupción de la vía glicolítica.
    • Juglone mejora la eficacia de la quimioterapia con cisplatino, lo que sugiere una posible combinación terapéutica.
    • Juglone representa un producto natural prometedor para el desarrollo de nuevos tratamientos contra el cáncer gástrico.